United Therapeutics Corp (UTHR)
237.00
+2.53
(+1.08%)
USD |
NASDAQ |
Apr 24, 16:00
237.18
+0.18
(+0.08%)
After-Hours: 20:00
United Therapeutics Cash and Short Term Investments (Quarterly): 2.994B for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.994B |
| September 30, 2023 | 2.876B |
| June 30, 2023 | 2.679B |
| March 31, 2023 | 2.863B |
| December 31, 2022 | 2.839B |
| September 30, 2022 | 2.616B |
| June 30, 2022 | 2.255B |
| March 31, 2022 | 2.268B |
| December 31, 2021 | 1.931B |
| September 30, 2021 | 2.000B |
| June 30, 2021 | 1.968B |
| March 31, 2021 | 1.731B |
| December 31, 2020 | 1.835B |
| September 30, 2020 | 1.580B |
| June 30, 2020 | 1.561B |
| March 31, 2020 | 1.544B |
| December 31, 2019 | 1.486B |
| September 30, 2019 | 1.57B |
| June 30, 2019 | 1.786B |
| March 31, 2019 | 1.605B |
| December 31, 2018 | 1.416B |
| September 30, 2018 | 1.238B |
| June 30, 2018 | 1.213B |
| March 31, 2018 | 1.257B |
| December 31, 2017 | 927.40M |
| Date | Value |
|---|---|
| September 30, 2017 | 1.211B |
| June 30, 2017 | 1.115B |
| March 31, 2017 | 1.156B |
| December 31, 2016 | 1.051B |
| September 30, 2016 | 1.033B |
| June 30, 2016 | 944.70M |
| March 31, 2016 | 975.10M |
| December 31, 2015 | 953.80M |
| September 30, 2015 | 921.84M |
| June 30, 2015 | 440.13M |
| March 31, 2015 | 656.86M |
| December 31, 2014 | 695.54M |
| September 30, 2014 | 767.66M |
| June 30, 2014 | 567.58M |
| March 31, 2014 | 760.49M |
| December 31, 2013 | 693.90M |
| September 30, 2013 | 716.84M |
| June 30, 2013 | 696.59M |
| March 31, 2013 | 670.64M |
| December 31, 2012 | 479.20M |
| September 30, 2012 | 503.46M |
| June 30, 2012 | 392.37M |
| March 31, 2012 | 408.97M |
| December 31, 2011 | 403.48M |
| September 30, 2011 | 694.60M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
1.486B
Minimum
Dec 2019
2.994B
Maximum
Dec 2023
2.125B
Average
1.968B
Median
Jun 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| Liquidia Corp | 83.68M |
| Esperion Therapeutics Inc | 82.25M |
| Vertex Pharmaceuticals Inc | 11.22B |
| Heron Therapeutics Inc | 80.41M |
| Aldeyra Therapeutics Inc | 142.82M |